MENU

PRLD Prelude Therapeutics Forecast, Technical & Fundamental Analysis

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients... Show more

PRLD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
PRLD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PRLD is expected to report earnings to fall 178.57% to 10 cents per share on November 05

Prelude Therapeutics PRLD Stock Earnings Reports
Q3'26
Est.
$0.11
Q2'26
Beat
by $0.09
Q1'26
Beat
by $0.10
Q4'25
Missed
by $0.07
Q3'25
Beat
by $0.11
The last earnings report on August 11 showed earnings per share of -14 cents, beating the estimate of -23 cents. With 396.20K shares outstanding, the current market capitalization sits at 312.03M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
79
Web
https://www.preludetx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
FLOKI.X0.000028N/A
+0.39%
FLOKI cryptocurrency
TFNS27.430.02
+0.08%
T. Rowe Price Financials ETF (TFNS)
TPIF36.81-0.31
-0.82%
Timothy Plan International ETF (TPIF)
RSIT21.49-0.23
-1.06%
Return Stacked International Stocks & Managed Futures ETF (RSIT)
PPH108.14-1.33
-1.21%
VanEck Pharmaceutical ETF (PPH)

PRLD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with SRPT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
-3.07%
SRPT - PRLD
38%
Loosely correlated
-3.57%
VSTM - PRLD
36%
Loosely correlated
-1.86%
MLTX - PRLD
35%
Loosely correlated
-1.97%
NAUT - PRLD
35%
Loosely correlated
+10.56%
IMNM - PRLD
35%
Loosely correlated
-2.88%
More
Prelude Therapeutics (PRLD) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com